Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- Unavailable
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- Unavailable
- Mejor venta
- Unavailable
- Punto medio
- Unavailable
- Spread
- Unavailable
- Ultimo trade
- Unavailable
- Profundidad
- No disponible
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|
Ventas
| Precio | Tamano |
|---|
Trades
Trades recientes
Latest visible trades for this market.
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 99% 1.03 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?No 10% 10 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 99% 200 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 94.1% 178.53 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 94% 1.06 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?No 40% 39 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 86% 2.03 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 86% 2.05 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 86% 1.16 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?No 40% 5 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?Yes 86% 3.49 shares
- FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?No 39% 2.56 shares